13 employees
Hyglos GmbH is a biotech company which develops bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria.
2009
$9M
from 2 investors over 2 rounds
Hyglos GmbH - a bioMérieux company raised $9M on August 23, 2005
Investors: KfW and Encavis AG